期刊文献+

异基因外周血干细胞移植后影响生存的危险因素65例分析 被引量:1

Analysis of risk factors for overall survival in 65 patients after allogeneic peripheral blood stem cell transplantation
下载PDF
导出
摘要 目的探讨异基因外周血干细胞移植(allo-PBSCT)后与长期生存相关的危险因素。方法对2000年6月至2008年12月65例行allo-PBSCT患者进行回顾性分析,选择年龄、性别、移植时疾病状态、供者类型、HLA相合情况、供受者血型、急性移植物抗宿主病(aGVHD)、慢性移植物抗宿主病(cGVHD)、出血性膀胱炎(HC)、巨细胞病毒(CMV)感染10个临床参数进行Cox单因素分析。将在单因素分析中P〈0.05作为有统计学意义的因素进行Cox多因素回归分析。生存率采用Kaplan-Meier曲线。结果除1例患者外,余64例均达稳定植活,0~Ⅰ度aGVHD为29例(45.3%),Ⅱ~Ⅳ度aGVHD 35例(54.7%)。发生cGVHD共29例(45.3%),其中局限型cGVHD 9例(31.0%),广泛型cGVHD 20例(69.0%)。1年总生存率(OS)为64.6%,5年OS为20.5%。随访至2009年12月,33例(50.8%)存活,生存期12~104个月,中位生存期51个月,死亡32例(49.2%),生存期1~96个月,中位生存期9个月。Cox回归分析移植时疾病状态和重度aGVHD的相对危险度分别是3.440和2.213。结论移植时疾病状态和重度aGVHD是影响造血干细胞移植长期生存的主要危险因素;在合适的疾病状态进行移植、积极防治aGVHD对移植成功非常重要。 Objective To analyze the risk factors related to long-term survival after allogeneic peripheral blood stem cell transplantation(allo-PBSCT).Methods Sixty-five patients after allo-PBSCT from Jun.2000 to Dec.2008 were retrospectively analyzed.Ten clinical parameters including age,sex,disease status,donor type,HLA matching,donor-recipient blood type,the incidence of acute graft versus host disease(aGVHD),chronic graft versus host disease(cGVHD),hemorrhagic cystitis(HC),cytomegalo virus(CMV) infection were selected for univariate analysis by using Cox regression.Factors with P0.05 were evaluated by Coxs regression.The survival rates were calculated by Kaplan-Meier curve.Results Sixty-four patients achieved sustained graft engraftment except one patient.Twenty-nine patients developed 0-Ⅰ degree aGVHD(45.3%) and 35 patients developed Ⅱ-Ⅳ degree aGVHD(54.7%).cGVHD occurred in 29 of 65 patients(45.3%),among which 9 patients(31.0%) were with local cGVHD,20 patients(69.0%) were with extensive cGVHD.The overall survival at one year was 64.6%.The overall survival at 5 years was 20.5%.Follow-up to Dec.2009,33 patients were alive and median survival duration was 51(12-104) months.Thirty-two patients died and median survival duration was 9(1-96) months.The Cox regression analysis showed that the relative risk degrees were 3.440 and 2.213,respectively.Conclusion The disease status at transplantation and severe aGVHD after transplantation were main risk factors affecting long-term survival.It is vital to select the suitable disease status and prevent,as well as treat aGVHD on hematopoietic stem cells transplantation.
出处 《临床荟萃》 CAS 2010年第18期1583-1586,共4页 Clinical Focus
关键词 血液肿瘤 外周血干细胞移植 移植物抗宿主病 存活率分析 危险因素 hematologic neoplasms peripheral blood stem cell transplantation acute graft versus host disease survival analysis risk factors
  • 相关文献

参考文献12

  • 1沈元元,张爱梅,李庆,孙自敏,翟志敏.异基因造血干细胞移植后CD4^+CD25^+调节性T细胞与移植物抗宿主病关系的研究[J].临床荟萃,2008,23(21):1524-1527. 被引量:3
  • 2Burnett AK. Acute myelold leukemia: treatment of adults under 60 years[J]. Rev Clin Exp Hematol,2002,6(1):26-45. 被引量:1
  • 3Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French American British (FAB) co operative group[J]. Br J Haematol, 1976,33(4): 451-458. 被引量:1
  • 4Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft versus-host disease in human recipients of marrow from HLA-matched sibling donors[J]. Transplantation, 1974, 18(4):295-304. 被引量:1
  • 5宋阿霞,杨栋林,魏嘉璘,阎嶂松,王玫,姜尔烈,黄勇,刘庆国,马巧玲,翟卫华,张荣莉,冯四洲,韩明哲.异基因造血干细胞移植治疗75例完全缓解期急性髓系白血病的疗效及预后分析[J].中国实验血液学杂志,2010,18(1):161-166. 被引量:13
  • 6Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers [J]. N Engl J Med,2001,344(3) : 175-181. 被引量:1
  • 7Baron F, Storb R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review[J]. Springer Semin Immunpathol,2004,26(1/2) :71-94. 被引量:1
  • 8Numar L. Haematopoietic stem cell transplantation: current status[J]. Natl Med J India,2007,20(3) :128-137. 被引量:1
  • 9King ME, Rowe JM. Recent developments in acute myelogenous leukemia therapy[J]. Oneologist, 2007,12 (12) : 14-21. 被引量:1
  • 10Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation(HCT)-speeific eomorbidity index: a new tool for riks assessment before allogeneic HCT[J]. Blood,2005,106 (8) :2912-2919. 被引量:1

二级参考文献37

  • 1张爱梅,翟志敏,徐修才,李庆,徐静玮,邬志伟,胡世莲,王怡平.标本放置时间及年龄对CD4^+CD25^+调节性T细胞的影响[J].免疫学杂志,2007,23(1):62-65. 被引量:13
  • 2Beutler H, Lichtman MA, Coller BS, et al. Williams Hematology[M]. 6th. New York: Me Graw-Hill Press, 2001 : 932-940. 被引量:1
  • 3Sakaguchi S. The origin of FOXP3-expressing CD4^+ regulatory T cells: thymus or periphery[J]. J Clin Invest, 2003,112 (9) : 1310-1312. 被引量:1
  • 4Taylor PA,Lees CJ, Blazar BR, et al. The infusion of ex vivo activated and expanded CD4^+ CD25^+ immune regulatory cells inhibits graft-verus-host disease lethality [J]. Blood, 2002, 99 (10) :3493-3499. 被引量:1
  • 5Zhai Z,Sun Z,Li Q,et al. Correlation of the CD4^+ CD25^high T- regulatory cells in recipients and their corresponding donors to acute GVHD[J]. Transpl Int,2007,20(5) :440-446. 被引量:1
  • 6Clark FJ, Gregg R, Piper K, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4^+ CD25^high regulatory T cells[J]. Blood, 2004, 103 (6) : 2410-2416. 被引量:1
  • 7Miura Y,ThoburnCJ,Bright EC, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease[J].Blood,2004,104(7):2187-2193. 被引量:1
  • 8Baecher-Allan C, Viglietta V, Hafler DA. Human CD4^ + CD25^ + regulatory T cells[J].Semin Immunol,2004,16(2):89-98. 被引量:1
  • 9Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity[J]. Curr Opin Immunol, 2004,16 (2) : 157-162. 被引量:1
  • 10Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4^+ CD25^+ regulatory T cells [J].Nat Immunol, 2003,4 (4) : 330-336. 被引量:1

共引文献46

同被引文献4

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部